Genomic analyses reveal that addiction risk is influenced by both shared behavioral traits and specific biological factors, ...

GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study ...

Hoebel and researchers in the department of psychology and the Princeton Neuroscience Institute have demonstrated patterns of craving and relapse, the third and final stage of addiction, that had ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

About 1 in 5 individuals develop a substance use disorder; more than 46 million people in the United States are affected at any given time. And yet, most people choose to use alcohol or other drugs ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Dr. Harriet de Wit's groundbreaking 45-year journey bridges animal and human drug research, reshaping global understanding of consciousness CHICAGO, Illinois, USA, 26 August 2025 -- In a revealing ...

The psychedelic drug ibogaine is a Schedule I controlled substance, but Kentucky lawmakers are considering a bill researching ...